Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TCTN2: a novel tumor marker with oncogenic properties.
Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R. Cano-Rodriguez D, et al. Among authors: terracciano l. Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221125 Free PMC article.
FAT1: a potential target for monoclonal antibody therapy in colon cancer.
Pileri P, Campagnoli S, Grandi A, Parri M, De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P, Cinti C, Jin B, Grandi G, Viale G, Terracciano L, Grifantini R. Pileri P, et al. Among authors: terracciano l. Br J Cancer. 2016 Jun 28;115(1):40-51. doi: 10.1038/bjc.2016.145. Epub 2016 Jun 21. Br J Cancer. 2016. PMID: 27328312 Free PMC article.
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer.
Grandi A, Santi A, Campagnoli S, Parri M, De Camilli E, Song C, Jin B, Lacombe A, Castori-Eppenberger S, Sarmientos P, Grandi G, Viale G, Terracciano L, Chiarugi P, Pileri P, Grifantini R. Grandi A, et al. Among authors: terracciano l. Oncotarget. 2016 Sep 27;7(39):63596-63610. doi: 10.18632/oncotarget.11550. Oncotarget. 2016. PMID: 27566589 Free PMC article.
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.
Bombaci M, Pesce E, Torri A, Carpi D, Crosti M, Lanzafame M, Cordiglieri C, Sinisi A, Moro M, Bernuzzi F, Gerussi A, Geginat J, Muratori L, Terracciano LM, Invernizzi P, Abrignani S, Grifantini R. Bombaci M, et al. Among authors: terracciano lm. Liver Int. 2019 Nov;39(11):2124-2135. doi: 10.1111/liv.14128. Epub 2019 May 15. Liver Int. 2019. PMID: 31033124
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC.
Carotenuto M, De Antonellis P, Liguori L, Benvenuto G, Magliulo D, Alonzi A, Turino C, Attanasio C, Damiani V, Bello AM, Vitiello F, Pasquinelli R, Terracciano L, Federico A, Fusco A, Freeman J, Dale TC, Decraene C, Chiappetta G, Piantedosi F, Calabrese C, Zollo M. Carotenuto M, et al. Among authors: terracciano l. Oncotarget. 2014 Jul 30;5(14):5736-49. doi: 10.18632/oncotarget.2169. Oncotarget. 2014. PMID: 25026278 Free PMC article.
OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA. Weixler B, et al. Among authors: terracciano l. Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940. Oncotarget. 2015. PMID: 26439988 Free PMC article.
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA, Guzzo G, Morandi A, Perra A, Menegon S, Masgras I, Trevisan E, Angioni MM, Fornari F, Quagliata L, Ledda-Columbano GM, Gramantieri L, Terracciano L, Giordano S, Chiarugi P, Rasola A, Columbano A. Kowalik MA, et al. Among authors: terracciano l. Oncotarget. 2016 May 31;7(22):32375-93. doi: 10.18632/oncotarget.8632. Oncotarget. 2016. PMID: 27070090 Free PMC article.
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
Lebok P, Roming M, Kluth M, Koop C, Özden C, Taskin B, Hussein K, Lebeau A, Witzel I, Wölber L, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Terracciano L, Krech RH, von der Assen A, Burandt E. Lebok P, et al. Among authors: terracciano l. Oncotarget. 2016 Dec 6;7(49):81322-81331. doi: 10.18632/oncotarget.13227. Oncotarget. 2016. PMID: 27835607 Free PMC article.
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
Wikman H, Westphal L, Schmid F, Pollari S, Kropidlowski J, Sielaff-Frimpong B, Glatzel M, Matschke J, Westphal M, Iljin K, Huhtala H, Terracciano L, Kallioniemi A, Sauter G, Müller V, Witzel I, Lamszus K, Kemming D, Pantel K. Wikman H, et al. Among authors: terracciano l. Oncotarget. 2014 May 30;5(10):3076-87. doi: 10.18632/oncotarget.1832. Oncotarget. 2014. PMID: 24833255 Free PMC article.
616 results